Paragon Therapeutics Appoints Susanna High As Chief Executive Officer

Nov 21, 2024•8 months ago

Position

Chief Executive Officer

Company

Paragon Therapeutics

Susanna High

WalthamTherapeuticsBiotechnology

Description

Susanna High, MBA, has been appointed as Chief Executive Officer at Paragon Therapeutics, where she will lead the team's efforts to propel the development of transformative therapies and accelerate their potential impact. High brings deep strategic and operational experience in building and leading fast-growing innovative biotech companies.

Company Information

Company

Paragon Therapeutics

Location

Waltham, Massachusetts, United States

About

Paragon Therapeutics, Inc., is a biotechnology company applying cutting-edge science and technology to shape the next generation of novel best-in-class complex biologics for major medical needs. The company is fueling a pipeline of transformative therapies and rapidly advancing them into clinical development.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Susanna hidden